Marinus Pharma CS
(MRNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 126,319 | 122,927 | 145,101 | 112,493 | 123,472 |
| Receivables | 2,489 | 2,629 | 2,473 | 4,201 | 2,650 |
| Other current assets | 0 | 557 | 1,059 | 0 | 0 |
| TOTAL | $135,071 | $131,678 | $153,491 | $120,924 | $129,798 |
| Non-Current Assets | |||||
| PPE Net | 2,989 | 2,499 | 2,650 | 1,984 | 1,894 |
| Other Non-Current Assets | 2,750 | 2,663 | 2,732 | 2,081 | 2,167 |
| TOTAL | $5,739 | $5,162 | $5,382 | $4,065 | $4,061 |
| Total Assets | $140,810 | $136,840 | $158,873 | $124,989 | $133,859 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,671 | 3,126 | 693 | 3,311 | 5,167 |
| Accrued Expenses | 14,865 | 16,207 | 15,155 | 13,383 | 10,954 |
| Other current liabilities | N/A | 21,233 | 21,828 | N/A | N/A |
| TOTAL | $19,536 | $40,566 | $37,676 | $16,694 | $16,121 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69,927 | 40,809 | 40,579 | 10,970 | N/A |
| Other Non-Current Liabilities | 10,942 | 1,979 | 2,124 | 2,266 | 2,404 |
| TOTAL | $80,869 | $42,788 | $42,703 | $13,236 | $2,404 |
| Total Liabilities | $100,405 | $83,354 | $80,379 | $29,930 | $18,525 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,140 | 37,003 | 36,766 | 36,732 | 36,633 |
| Common Shares | 37 | 37 | 37 | 37 | 37 |
| Retained earnings | -430,066 | -410,705 | -382,400 | -362,893 | -339,070 |
| Other shareholders' equity | 4,302 | 4,302 | 4,302 | 4,302 | 4,469 |
| TOTAL | $40,405 | $53,486 | $78,494 | $95,059 | $115,334 |
| Total Liabilities And Equity | $140,810 | $136,840 | $158,873 | $124,989 | $133,859 |